Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists

J Pediatric Infect Dis Soc. 2020 Jul 13;9(3):281-284. doi: 10.1093/jpids/piaa057.
No abstract available

Keywords: nephrotoxicity; pharmacokinetics and pharmacodynamics; target attainment; vancomycin; vancomycin consensus guidelines.

Publication types

  • Comment

MeSH terms

  • Anti-Bacterial Agents
  • Child
  • Humans
  • Methicillin
  • Methicillin-Resistant Staphylococcus aureus*
  • Pharmacists
  • Staphylococcal Infections*
  • United States
  • Vancomycin

Substances

  • Anti-Bacterial Agents
  • Vancomycin
  • Methicillin